A carregar...

Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors

BACKGROUND: Assessment of the status of tumor biomarkers in individual patients would facilitate personalizing treatment strategy, and continuous monitoring of those biomarkers and their binding process to the therapeutic drugs would provide a means for early evaluation of the efficacy of therapeuti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Ardeshirpour, Yasaman, Sackett, Dan L., Knutson, Jay R., Gandjbakhche, Amir H.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5884746/
https://ncbi.nlm.nih.gov/pubmed/29619584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0384-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!